clarithromycin has been researched along with Gastritis in 324 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 80 (24.69) | 18.2507 |
| 2000's | 128 (39.51) | 29.6817 |
| 2010's | 98 (30.25) | 24.3611 |
| 2020's | 18 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, SH; Lai, CH; Rao, YK; Sing, YT; Tzeng, YM | 1 |
| Chang, CS; Chen, LY; Kao, MC; Kuo, SC; Lai, CH; Lin, CD; Lin, HJ; Liu, JF; Lu, DY; Sing, YT; Tang, CH | 1 |
| Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
| He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X | 1 |
| Cao, LJ; Cao, WL; Che, Y; Ding, CJ; Huang, H; Wang, Y; Wu, JW; Xu, WF; Zhang, Q | 1 |
| Esmaeili, S; Maghami, AA; Mobarez, AM; Nikkhah, M; Sadeghi, A; Yadegar, A | 1 |
| Abbasher Hussien Mohamed Ahmed, K; Ashfaq, F; Kumari, V; Seetlani, NK; Tahir, MJ; Waheed, S; Yousaf, Z | 1 |
| Hoang, VT; Tran, TNQ; Tran, TQA; Vu, DL; Vu, TB | 1 |
| Koliada, AK; Kovalova, AV; Nikulina, LM; Solovyova, GA; Svintsitskyi, IA | 1 |
| Dohi, O; Hara, T; Inada, Y; Inoue, K; Itoh, Y; Iwai, N; Kagawa, K; Komaki, T; Konishi, H; Naito, Y; Oka, K; Okuda, T; Tsuji, T | 1 |
| Castaño, R; Navas, MC; Roldán, IJ | 1 |
| Arévalo, A; Otero, WA; Trespalacios, AA | 1 |
| Bair, MJ; Chen, CL; Chen, HH; Chia, SL; Chiang, TH; Chu, CH; Chuang, SL; Chung Lo, YT; Jou, YY; Lee, YC; Lei, WY; Lin, CC; Su, WW; Tian, HW; Wang, YW; Wu, CY; Wu, MS | 1 |
| Aung, NM; Cooper, D; Danta, M; Hanson, J; Kyi, MM; Myint, NPST; Sain, K; Waiyan, S; Zaw, TT | 1 |
| Chen, YH; Hsu, PI; Kao, JY; Kao, SS; Kuo, CH; Peng, NJ; Shie, CB; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC | 1 |
| Florez Bracho, L; Lasa, JS; Paz, S; Zubiaurre, I | 1 |
| Akbaş, T; Şenocak Taşçı, E | 1 |
| Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
| Jeon, H; Kang, SC; Kim, BY; Kim, SE; Lee, WK; Memon, A | 1 |
| Dang, NQH; Ha, TMT; Le, NDK; Nguyen, ST; Nguyen, TH; Nguyen, TMT; Pham, TTH; Tran, VH | 1 |
| Graham, DY; Lu, H; Shiotani, A | 1 |
| Hu, F; Liu, Y; Teng, G; Wang, H; Wang, W; Wu, T | 1 |
| Pan, L; Tang, G; Tang, Y; Wei, Z; Zhou, S; Zhu, H | 1 |
| Kizawa, K; Kosone, T; Marubashi, K; Takagi, H; Takakusagi, S; Tojima, H; Yokoyama, Y | 1 |
| Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY | 1 |
| Fuchigami, T; Kawasaki, K; Kurahara, K; Matsumoto, T; Nakamura, S; Ohtsu, K; Oshiro, Y | 1 |
| Bacci, B; Mansfield, CS; Santos, L; Sharman, MJ | 1 |
| Hiroi, S; Kawakami, K; Sugano, K; Tanaka, S | 1 |
| Ang, TL; Aung, MM; Chakravuth, O; Chotivitayatarakorn, P; Fock, KM; Goh, KL; Graham, D; Harnsomburana, P; Kositchaiwat, C; Lee, YC; Leelakusolvong, S; Leow, A; Mahachai, V; Mairiang, P; Maneerattanaporn, M; Mya, SM; Pisespongsa, P; Pittayanon, R; Rani, A; Rasachak, B; Rojborwonwitaya, J; Sansak, I; Sollano, JD; Sugano, K; Syam, AF; Treeprasertsuk, S; Trong Quach, D; Vannarath, S; Vilaichone, RK; Wiwattanachang, O; Yamaoka, Y | 1 |
| Mori, H; Suzuki, H | 1 |
| Bazzoli, F; Eusebi, LH; Rabitti, S; Zagari, RM | 1 |
| Benedeto-Stojanov, D; Grgov, S; Radovanović-Dinić, B; Tasić, T | 1 |
| Auesomwang, C; Chey, WD; Kiratisin, P; Leelakusolwong, S; Maneerattanaporn, M; Tanwandee, T | 1 |
| Chang, YW; Cho, JH; Jang, JY; Kim, JW; Ko, WJ; Moon, JR; Oh, CH; Oh, SJ; Park, YM | 1 |
| Cho, JH; Jeon, SR; Jin, SY; Kim, HG; Park, S | 1 |
| Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S | 1 |
| Ha, TMT; Le, PTQ; Phan, TN; Tran, TNH; Tran, VH | 1 |
| Salar, A | 1 |
| Bizzarri, B; De' Angelis, GL; Di Mario, F; Gaiani, F; Iuliano, S; Kayali, S; Leandro, G; Manfredi, M; Minelli, R | 1 |
| Shahbazi, S; Vahdat Shariatpanahi, Z | 1 |
| Chen, YH; Hsu, PI; Kao, JY; Kao, SS; Pan, CY; Peng, NJ; Tsai, KW; Tsai, TJ; Tsay, FW; Wu, DC | 1 |
| Abu-Elhija, O; Bragazzi, NL; Ghantous, M; Khoury, T; Mahamid, M; Mari, A; Watad, A | 1 |
| Chayama, K; Kitadai, Y; Masaki, S; Matsuo, K; Matsuo, T; Naito, T; Sentani, K; Takigawa, H; Tanaka, S; Urabe, Y; Yuge, R | 1 |
| Abbas, Z; Abid, S; Ahmed, R; Hamid, S; Jafri, W; Mumtaz, K; Yakoob, J | 1 |
| Arts, J; De Cooman, L; Ducatelle, R; Flahou, B; Haesebrouck, F; Joosten, M; Meyns, T; Pasmans, F; Smet, A | 1 |
| Feng, Z; Hu, S; Huang, J; Xu, Y; Zhang, M | 1 |
| Kaul, KL; Mangold, KA; Regner, M; Schmitt, BH; Thomson, RB | 1 |
| Botero, ML; Cárdenas, A; Forero, JD; Rey, M; Sierra, F | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H; Suzuki, M; Takahashi, M | 1 |
| Ghadir, MR; Iranikhah, A; Sarkeshikian, SS | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Bassetto, MA; Cecchini, MP; De Franceschi, L; Fontana, R; Marcolini, L; Osculati, F; Pegoraro, M; Pellegrini, C; Sbarbati, A | 1 |
| Ben-Dor, D; Delgado, JS; Landa, E | 1 |
| Einck, L; Makobongo, MO; Merrell, DS; Peek, RM | 1 |
| Furuta, T; Ichikawa, H; Kodaira, C; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| Asaoka, D; Hojo, M; Matsumoto, K; Nagahara, A; Osada, T; Sasaki, H; Watanabe, S | 1 |
| Abdalla, AF; Al-Hussaini, AS; El-Baz, R; Galal, A; Settin, A | 1 |
| Mengnan, Z; Wei, Z; Wen, G; Yali, Z; Ying, L | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, G; Picchio, M; Tursi, A | 1 |
| Chen, BP; Chen, YH; Huang, GR; Huang, XF; Huang, YQ; Huang, ZS; Li, XH; Mo, XQ; Qin, YC; Tang, HY; Wang, LY; Wei, HY; Wei, LD; Zhao, LJ | 1 |
| Ahn, JY; Choi, KD; Choi, KS; Gong, EJ; Jung, HY; Kim, DH; Kim, JH; Lee, GH; Lee, JH; Lim, H; Song, HJ; Yun, SC | 1 |
| Kato, M | 1 |
| Hwang, JH; Jang, ES; Jeoung, SH; Jung, HC; Kang, KK; Kim, JW; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Acosta, CP; Hurtado, FA; Trespalacios, AA | 1 |
| Bani-Sadr, F; Boulagnon, C; Diebold, MD; Hentzien, M; Jaussaud, R; Lambert, D; Nguyen, Y; Ramaholimihaso, F; Rouger, C | 1 |
| Arj, A; Dastehgoli, K; Keshavarz Azizi Raftar, S; Mirzaei Ghazi Kalayeh, H; Moniri, R; Mousavi, SG; Razavi Zadeh, M; Saffari, M | 1 |
| Tu, S; Yang, H | 1 |
| Choi, YJ; Kim, JM; Kim, N; Kwon, YH; Lee, DH; Lee, JY; Lee, S; Nam, RH; Park, YS; Shin, CM; Suh, JH; Yoon, H; Yoon, K | 1 |
| Mahachai, V; Siramolpiwat, S; Srinarong, C; Vilaichone, RK; Wongcha-um, A | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Agibalov, AN; Dorofeev, AÉ; Kugler, TE; Rudenko, NN; Sibilev, AV; Tomash, OV | 1 |
| Cheung, DY; Chung, WC; Jun, EJ; Kim, BW; Kim, JI; Kim, SS; Lee, HJ; Lee, JS; Oh, JH | 1 |
| Dinca, EB; Dinca, RV; Skinner, A; Tudose, C | 1 |
| Baltz, AC; Berry, AC; Nakshabendi, R | 1 |
| Ang, D; Ang, TL; Dhamodaran, S; Fock, KM; Kwek, AB; Ong, J; Song, M; Tan, J; Teo, EK | 1 |
| Al-Adhba, HS; Ben Chaabane, N | 1 |
| Bari, Z; Fakheri, H; Hosseini, V; Maleki, I; Metanat, HA; Taghvaei, T; Valizadeh, SM | 1 |
| Kotsiubniak, LA; Koval', VIu; Moskal', OM | 1 |
| Cho, KB; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, HS; Kwon, JG; Lee, DW; Lee, SH; Park, JB; Park, KS; Yang, CH | 1 |
| Kim, BW; Kim, JS; Park, SM | 1 |
| Klain, V; Timmerman, L | 1 |
| Bai, P; Ding, Y; Luo, Y; Xiao, XM; Zhou, LY | 1 |
| Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, S; Leeanansaksiri, W; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T | 1 |
| Chun, J; Kim, BG; Kim, BS; Kim, JS; Kim, JW; Koh, SJ; Lee, KL; Oh, B | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Angelidou, I; Arampatzioglou, A; Dellaporta, E; Kambas, K; Konstantinidis, T; Kouklakis, G; Mitroulis, I; Mitsios, A; Panopoulou, M; Ritis, K; Skendros, P; Tsironidou, V | 1 |
| Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, SJ; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T | 1 |
| Itoh, F; Kato, M; Kudo, T; Mabe, K; Miyamoto, S; Oikawa, R; Ono, S; Sakamoto, N; Watanabe, Y; Yamamoto, H | 1 |
| Arnold, CA; Coss, E; Cryer, B; Doern, CD; Dunbar, KB; Lam-Himlin, DM; Mitui, M; Okwara, C; Park, JY; Thung, I; Valasek, MA | 1 |
| Imamura, T; Imashuku, S; Ohmae, T; Osamura, T; Todo, K | 1 |
| Amorena, E; Campillo, A; Kutz, M; LaIglesia, M; Ostiz, M | 1 |
| Oberhofer, E | 1 |
| Fukuda, Y; Kamiya, S; Kato, M; Kikuchi, S; Mabe, K; Okuda, M; Osaki, T | 1 |
| Alarcón-Millán, J; Betancourt-Linares, R; Castañón-Sánchez, CA; Cortés-Malagón, EM; Cruz-Del Carmen, I; De Sampedro-Reyes, J; Fernández-Tilapa, G; Román-Román, A | 1 |
| Asaka, M; Kato, M; Kudo, T; Mabe, K; Nakamura, M; Sakamoto, N; Sato, M; Shiratori, S; Takakuwa, Y; Yoshii, S | 1 |
| Choi, H; Ji, JS; Kim, BW; Kim, JS; Park, SM | 1 |
| Phaw, NA; Tsai, HH | 1 |
| Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gasbarrini, A; Gisbert, JP; Graham, DY; Hunt, R; Kuipers, EJ; Malfertheiner, P; Megraud, F; Moayyedi, P; O'Morain, CA; Rokkas, T; Rugge, M; Selgrad, M; Suerbaum, S; Sugano, K | 1 |
| Dissemond, J; Körber, A | 1 |
| Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA | 1 |
| Choi, MG; Chung, IS; Dong, MS; Lee, SB; Oh, JH; Park, YI; Yoo, HW | 1 |
| Isomoto, H; Ito, M; Kohno, S; Nishiyama, H; Okamoto, K; Shikuwa, S | 1 |
| Carrobles Jiménez, JM; Cuena Boy, R; de Artaza Varasa, T; García Vela, A; Martín Escobedo, R; Pérez-Grueso, MJ; Rodríguez Merlo, R; Valle Muñoz, J | 1 |
| Aigner, T; Fritzsch, J; Krügel, V; Pluta, L; Schütz, A | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Esedov, EM; Magomedéminova, AS | 1 |
| Abut, E; Bölükbaş, C; Bölükbaş, FF; Dalay, AR; Güveli, H; Kurdaş, OO; Yaşar, B | 1 |
| Breslin, N; Fitzgerald, N; Murphy, P; Nami, A; O'connor, A; O'connor, H; O'moráin, C; Qasim, A; Ryan, B; Taneike, I | 1 |
| Lassnig, RM | 1 |
| Huang, X; Li, Y; Shi, R; Yao, L; Zhang, G | 1 |
| Ayadi, A; Ben Mansour, K; Boubaker, J; Burucoa, C; Cheikh, I; Chouaib, S; Fekih, M; Fendri, C; Filali, A; Hriz, MB; Kallel, L; Karoui, S; Labbene, M; Maherzi, A; Mami, NB; Masmoudi, A; Matri, S; Najjar, T; Sfar, MT; Siala, N; Zarrouk, S; Zribi, M | 1 |
| Cabras, A; Carbone, A; Devizzi, L; Gianni, AM; Mirabile, A | 1 |
| Arisawa, T; Hirata, I; Ishizuka, T; Maeda, Y; Nakamura, M; Okubo, M; Shibata, T; Tahara, T; Yonemura, J; Yoshioka, D | 1 |
| Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
| Albayrak, B; Altuntas, Y; Bayraktar, B; Bugdaci, MS; Sokmen, M; Toksoy, B; Zuhur, SS | 1 |
| Binder, C; Bruckdorfer, A; Giczi, H; Graf, U; Hammer, K; Hirschl, AM; Innerhofer, A; Makristathis, A; Vécsei, A | 1 |
| El-Halabi, M; Ghaith, O; Hashash, JG; Maasri, K; Malli, A; Mansour, NM; Sharara, AI; Sukkarieh, I | 1 |
| Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
| Annibale, B; Hassan, C; Sbrozzi-Vanni, A; Severi, C; Vannella, L; Zullo, A | 1 |
| Belousova, NL; Firsova, LD; Goncharenko, LS; Govorun, VM; Ianova, OB; Kashnikov, VS; Kim, VA; Masharova, AA; Shcherbakov, PL; Shcherbakova, MIu | 1 |
| Chang, LL; Chen, YH; Huang, YK; Kuo, CH; Kuo, FC; Lee, YC; Wang, SS; Wang, TH; Wang, WM; Wu, DC; Wu, MC | 1 |
| Choi, HS; Chun, HJ; Jeen, YT; Keum, B; Kim, CD; Kim, YS; Lee, HS; Park, SH; Ryu, HS; Seo, YS; Um, SH | 1 |
| Ang, D; Ang, TL; Chiam, P; Fock, KM; Teo, EK; Wang, L | 1 |
| Hashino, S; Ohe, M | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN | 1 |
| Atherton, JC; Barrett, DA; Jenkins, D; Jordan, N; Shaw, PN; Sherwood, PV; Spiller, RC; Wibawa, JI | 1 |
| Abe, H; Arita, T; Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S | 1 |
| Haga, K; Hirayama, F; Iwao, E; Takagi, S; Yamamoto, K; Yokoyama, Y | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM | 1 |
| Orr, CF; Rowe, DB | 1 |
| Dupont, C; Kalach, N; Raymond, J | 1 |
| Amann, G; Binder, C; Crone, J; Granditsch, G; Hirschl, AM; Huber, WD; Innerhofer, A | 1 |
| Iihara, K; Kaise, M; Miwa, J; Oda, Y; Ohta, Y; Suzuki, N | 1 |
| Chayama, K; Haruma, K; Ito, M; Kamada, T; Masuda, H; Miyamoto, M; Nishisaka, T; Sumioka, M; Tanaka, S; Yoshihara, M | 1 |
| Biagi, GL; Cantelli-Forti, G; Gatta, L; Miglioli, M; Paolini, M; Perna, F; Ricci, C; Sapone, A; Tampieri, A; Trespidi, S; Vaira, D | 1 |
| Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
| Uthaisaengsook, W | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, PN | 1 |
| Hino, M; Kokubo, Y; Kudo, S; Narato, R; Ono, Y; Soma, T; Tanaka, Y; Uehara, T; Yoshioka, Y | 1 |
| Ando, T; Hasegawa, T; Ina, K; Kusukami, K; Nohata, K; Ota, M; Tsuzuki, T | 1 |
| El-Omar, EM; Furuta, T; Ishizaki, T; Ohashi, K; Rabkin, CS; Shirai, N; Sugimura, H; Xiao, F | 1 |
| Jüttner, S; Kirsch, C; Lehn, N; Miehlke, S; Pfeuffer, T; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Fujioka, T; Kobayashi, I; Muraoka, H; Nasu, M; Nishida, M; Saika, T | 1 |
| Furuta, Y; Miyasaka, K; Sugiyama, T; Yoshioka, M | 1 |
| Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C | 1 |
| Nakagawa, S; Suzuki, K; Taneike, I; Yamamoto, T | 1 |
| Ishii, H; Kamiya, AG; Masaoka, T; SuzukiKurabayashi, HK | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Tanida, S | 1 |
| Chan, FK; Ching, JY; Lau, JY; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Cinar, K; Ozden, A; Soykan, I | 1 |
| Blanche, P; Chauvelot-Moachon, L; Kélaïdi, C; Nazal, EM; Pajot, O; Rollot, F | 1 |
| Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K | 1 |
| Schuster, M | 1 |
| Chang, CC; Chen, SH; Fang, CL; Hsieh, CR; Lee, YJ; Lien, GS; Lou, HY; Pan, S | 1 |
| Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
| Hershko, C; Hoffbrand, AV; Keret, D; Lahad, A; Maschler, I; Monselise, Y; Souroujon, M | 1 |
| Egashira, T; Furuta, T; Hishida, A; Ishizaki, T; Kenmotsu, K; Kodaira, M; Nagano, M; Nakamura, A; Ohashi, K; Sagehashi, Y; Shirai, N; Sugimoto, M; Ueda, K; Yoneyama, M | 1 |
| Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nakao, H; Ogasawara, N; Ohara, H; Okada, N; Oshima, T; Sano, H; Sasaki, M; Sobue, S; Tanida, S | 1 |
| Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB | 1 |
| Chen, X; Jia, Y; Liu, SJ; Shen, SR; Tang, WL; Wang, F; Wang, XY; Xu, CX | 1 |
| Carvalhaes, A; Magalhães, AF; Natan-Eisig, J; Paraíso-Ferraz, JG; Trevisan, M; Zaterkaad, S | 1 |
| Chen, FB; Chen, J; Chen, XJ; Li, ZY; Yu, JD; Zhang, XP | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Cheng, H; Hu, FL | 1 |
| Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC | 1 |
| Chan, AO; Chan, CK; Cheung, HK; Kwong, YL; Lai, KC; Lam, SK; Peng, JZ; Rashid, A; Wong, BC; Yuen, MF | 1 |
| Bayerdörffer, E; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neuber, F; Rappel, S; Seitz, G; Stolte, M | 1 |
| Deguchi, R; Kobayashi, I; Kobayashi, K; Kurumada, T; Masui, A; Matsushima, M; Mine, T; Muraoka, H; Shirai, T; Suzuki, T; Takagi, A; Watanabe, K; Watanabe, S | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Franceschi, M; Leandro, G; Perri, F; Pilotto, A | 1 |
| Akarca, US; Aydin, A; Musoğlu, A; Onder, GF; Tekin, F; Tunçyürek, M | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Shirai, N; Sugimoto, M | 1 |
| Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA | 1 |
| Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR | 1 |
| Ziemniak, W | 1 |
| Stege, PW; Vega, AE | 1 |
| Bowlus, CL; Date, Y; Hoshino, H; Ishino, Y; Kita, H; Nakazato, M; Ohnishi, H; Osawa, H; Satoh, K; Shiiya, T; Sugano, K; Ueno, H; Watanabe, E | 1 |
| Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y | 1 |
| Demiray, E; Yilmaz, O | 1 |
| Kumala, W; Rani, A | 1 |
| Arakawa, Y; Hatta, Y; Hayashi, I; Iwamoto, M; Kato, K; Kurihara, R; Kurosaka, H; Matsukawa, Y; Mizuno, S; Sawada, S | 1 |
| Burdina, EG; Ivanova, OI; Minushkin, ON; Shuleshova, AG; Volodin, DV; Zverkov, IV | 1 |
| Cindoruk, M; Deger, SM; Kan, E; Karakan, T; Unal, S; Yetkin, I | 1 |
| Haruma, K; Iishi, H; Ishiguro, S; Kamada, T; Merchant, JL; Nakae, Y; Shiotani, A; Tatsuta, M; Uedo, N | 1 |
| Barbatzas, C; Demonakou, M; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koussoulas, V; Spyridaki, E; Vaki, I; Vassiliou, S | 1 |
| Fujioka, T; Furuta, T; Hishida, A; Kodaira, C; Murakami, K; Nakamura, A; Nishino, M; Okimoto, T; Okuda, M; Shirai, N; Soya, Y; Sugimoto, M | 1 |
| Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK | 1 |
| Amenta, PS; Das, KK; Das, KM; Geng, X; Kohgo, Y; Lin, JJ; Tanabe, H; Tanaka, A; Watari, J | 1 |
| Landivar, B; Moncayo, M; Parrales, J; Robles-Jara, C; Robles-Medranda, C | 1 |
| Schepp, W | 1 |
| Armstrong, D; Blum, AL; Kreiss, C | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Beattie, S; Cahill, RJ; Hamilton, H; Kilgallen, C; O'Morain, C; Xia, H | 1 |
| Johnson, CD; Ozmen, MM | 1 |
| Getz, HD; Metz, DC | 1 |
| Coll, I; Espinós, JC; Forné, M; Garau, J; Tresserra, F; Viver, JM | 1 |
| Adamek, RJ; Opferkuch, W; Wegener, M | 1 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Ricken, D; Szymanski, C; Wegener, M | 1 |
| Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M | 1 |
| Domschke, W | 1 |
| Cuccurullo, F; Di Iorio, P; Laterza, F; Mezzetti, A; Neri, M; Seccia, G; Susi, D | 1 |
| Labenz, J; Stolte, M | 2 |
| Nasu, M | 1 |
| Diehl, HG | 1 |
| Dammann, HG | 1 |
| Bazzoli, F | 1 |
| Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
| Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C | 1 |
| Fujioka, T; Kodama, R; Kubota, T; Murakami, K; Nagai, J; Nasu, M; Nishizono, A; Tokieda, M | 1 |
| Labenz, J | 2 |
| Brill, S; Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Bock, H; Mares, A | 1 |
| Kajiwara, M; Kawada, H; Kidaira, K; Kimura, K; Nishifuku, K; Sato, K; Sohara, H; Taniguchi, Y; Wang, XM | 1 |
| Dohil, R; Hassall, E; Israel, DM | 1 |
| Drumm, B; Durnin, M; Goggin, N; Moriarty, S; Rowland, M; Walsh, D | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Siehoff, S; Tillenburg, B | 1 |
| Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N | 1 |
| Aka, H; Gullu, IH; Kadayifçi, A | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Ebina, K; Kato, S; Naganuma, H; Takeyama, J | 1 |
| Biemond, I; Götz, JM; Lamers, CB; Offerhaus, GJ; Thio, JL; Veenendaal, RA; Verspaget, HW | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Hirakawa, T | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Cervantes Bustamante, R; Cuevas, S; Mata Rivera, N; Oyervides Garcia, I; Ramirez Mayans, JA; Zamora Davila, E; Zarate Mondragón, FE | 1 |
| Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Dettmer, A; Fraser, AG; O'Morain, C; Rambow, A; von Fritsch, E | 1 |
| Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Minocha, A; Srinivasan, R | 1 |
| Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D | 1 |
| Berg, DE; Blaser, MJ; Dubois, A; Fiala, N; Heman-Ackah, LM; Perez-Perez, GI | 1 |
| Berquist, WE | 1 |
| Carnicer, J | 1 |
| Bei, L; Chen, S; Chen, Z | 1 |
| Gavura, SR; Nusinowitz, S | 1 |
| Cummins, AG; Grove, DI; Koutsouridis, G | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Kimura, K; Sato, K | 1 |
| Aoyama, N | 1 |
| Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Manzionna, G; Parente, F; Vago, L | 1 |
| Arber, N; Brill, S; Bujanover, Y; Halpern, Z; Moshkowitz, M; Reif, S; Ringel, Y | 1 |
| Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M | 1 |
| Adler, G; Ellenrieder, V; Fensterer, H; Glasbrenner, B; Waurick, M | 1 |
| Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
| Meier, E; Meining, A; Stolte, M | 1 |
| Alfvén, G; Bergström, M; Casswall, TH; Dahlström, KA; Drapinski, M | 1 |
| Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T | 1 |
| Braegger, CP; Schultz-Süchting, F; Stallmach, T | 1 |
| Finkel, Y; Sandstedt, B; Tirén, U | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA | 1 |
| Tytgat, GN; van 't Hoff, BW; van der Ende, A; van der Hulst, RW | 1 |
| Abdul Aal, GM; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, M; Ukabam, S | 1 |
| Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Acciardi, C; Ali', A; Gatta, L; Holton, J; Landi, F; Menegatti, M; Miglioli, M; Ricci, C; Vaira, D | 1 |
| Chen, X; Haruma, K; Kajiyama, G; Kamada, T; Kawamura, Y; Komoto, K; Mihara, M; Sumii, K; Tahara, K; Yoshihara, M | 1 |
| Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
| Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Cryer, B; Feldman, M; Lee, E; Sammer, D; Spechler, SJ | 1 |
| Bortolotti, M; Brunelli, F; Mari, C; Miglioli, M; Sarti, P | 1 |
| Axon, AT; Bardhan, KD; Braun, W; Cooper, BT; Dillon, J; Gatz, G; Tildesley, G; Wyatt, JI | 1 |
| Hoshi, T; Kato, K; Nagura, H; Ohara, S; Sasano, H; Shimosegawa, T; Toyota, T | 1 |
| Dammann, HG; Fölsch, UR; Hahn, EG; Kirchner, T; Kist, M; Klör, HU; Strobel, S; von Kleist, DH | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C | 1 |
| Berkowitz, D; Naveh, Y; Rosenthal, E; Shamaly, H | 1 |
| Blackington, E | 1 |
| Lin, CH; Peters, J; Rabah, R; Shashidhar, H; Thomas, R; Tolia, V | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Adamsson, I; Edlund, C; Nord, CE | 1 |
| Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
| Imai, T; Konno, M; Muraoka, S; Takahashi, M | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Nuciforo, G | 1 |
| Fukuda, S; Munakata, A; Nishiya, D; Shimoyama, T; Suto, T; Umegaki, N | 1 |
| Braegger, CP; Frank, F; Stallmach, T; Stricker, T | 1 |
| Botta, F; Chiarbonello, B; Fasoli, A; Giannini, E; Lantieri, PB; Malfatti, F; Risso, D; Romagnoli, P; Savarino, V; Testa, R | 1 |
| Ducóns, JA; Ferrero, M; Gomollón, F; Santolaria, S; Sicilia, B; Sierra, E | 1 |
| Ansaldi, N; Gaido, F; Lerro, P; Lombardo, L; Morra, I; Perrucci, V | 1 |
| Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Axon, AT; Bardhan, K; Dixon, MF; Moayyedi, P; Peacock, R; Walan, A; Wason, C | 1 |
| Aller, R; Boixeda, D; Caballero, C; Cantón, R; Cordero, JM; de la Calle, H; de Luis, DA | 1 |
| Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T | 1 |
| Bauerfeind, P; Blum, AL; Brassart, D; Corthésy-Theulaz, I; Felley, CP; Kaufmann, M; Michetti, P; Pfeifer, A; Rivero, JL; Sipponen, P; Wiesel, PH | 1 |
| Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Gopanpallikar, A; Rathi, P; Sawant, P | 1 |
| Palka, M; Zwolińska-Wcisło, M | 1 |
| Goshi, S; Ohara, T; Tamura, Y; Taneike, I; Yamamoto, T; Zhang, HM | 1 |
| Kawamura, K; Kimura, M; Mukai, K; Nakamura, S; Nakamura, T; Sawa, H; Shiku, H; Suzuki, H; Toyoda, H; Yamaguchi, M | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Chang, MH; Jeng, YM; Ni, YH; Yang, JC; Yang, YJ | 1 |
| Bidaut-Mazel, C; Bruley Des Varannes, S; Colin, R; Fléjou, JF; Meunier, A; Zaïm, M | 1 |
| Asato, Y; Mukai, M; Ochiai, A; Shimoyama, Y | 1 |
| Bentivoglio, AR; Carloni, E; Cicconi, V; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Manna, R; Nocente, R; Servidei, S; Silveri, NG | 1 |
| Bayerdörffer, E; Müller, H; Rappel, S; Stolte, M; Wündisch, T | 1 |
| Bigard, MA | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
| Baeva, N; Ianev, N; Kiselova, A; Krŭstev, D; Krŭstev, N; Vichev, E | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P | 1 |
| Alpen, B; Neubauer, A; Röbbecke, J; Stolte, M; Wündisch, T | 1 |
| Bhattacharyya, H; Hopkins, RJ; King, EC; Meyer, JM; Morris, D; Siepman, NY; Silliman, NP; Sugg, JE; Wang, W; Zhang, J | 1 |
| Azuma, T; Dojo, M; Kuriyama, M; Muramatsu, A; Ohtani, M; Saito, T | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Bavbek, N; Koçkar, C; Oztürk, M | 1 |
| Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M | 1 |
| Sung, JJ; Wu, JC | 1 |
| Messerer, P; Ott, MG; Riemann, JF; Schauwecker, P; Schilling, D; Zober, A | 1 |
| Fujimura, S; Kato, S; Kawamura, T; Watanabe, A | 1 |
| Baena, JM; García, M; Hernández, MR; Hidalgo, A; Jiménez, S; López, C; Rams, F | 1 |
| Chong, SK; Uc, A | 1 |
| Isomoto, H; Kohno, S | 1 |
| Kato, K; Nagura, H; Noguchi, K; Ohara, S; Sekine, H; Shimosegawa, T; Suzuki, T | 1 |
| Arand, F; Bayerdörffer, E; Klein, U; Knippig, C; Leodolter, A; Malfertheiner, P; Nilius, M | 1 |
| Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S | 1 |
30 review(s) available for clarithromycin and Gastritis
| Article | Year |
|---|---|
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance.
Topics: Amoxicillin; Antimicrobial Stewardship; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Failure; Treatment Outcome | 2021 |
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors; Taiwan; Tetracycline; Thailand; Treatment Outcome; United States | 2018 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; Gastritis; Health Planning Guidelines; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Metronidazole; National Health Programs; Quinolones; Rifabutin; Stomach Neoplasms | 2018 |
Treatment of Helicobacter pylori infection: A clinical practice update.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Failure | 2018 |
Gastric MALT lymphoma and Helicobacter pylori.
Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Organometallic Compounds; Practice Guidelines as Topic; Proton Pump Inhibitors; Salvage Therapy; Stomach Neoplasms | 2019 |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicable Disease Control; Cytochrome P-450 CYP3A Inhibitors; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea; Tinidazole | 2014 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2014 |
Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rho Guanine Nucleotide Exchange Factors; Treatment Outcome | 2015 |
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.
Topics: Anti-Infective Agents; Aza Compounds; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Proton Pump Inhibitors; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Retreatment | 2010 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
[What is Helicobacter pylori?: associated diseases in human].
Topics: Amoxicillin; Animals; Clarithromycin; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 2004 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
[Eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Stomach Neoplasms; Sulfoxides | 2005 |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence | 2007 |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].
Topics: Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic | 1995 |
Omeprazole, Helicobacter pylori, and gastritis.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1994 |
[Current therapy of Helicobacter pylori infection].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1994 |
[Helicobacter pylori infections].
Topics: Amphotericin B; Bismuth; Clarithromycin; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Tetracyclines | 1993 |
[Current developments in Helicobacter pylori therapy].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Stomach Ulcer | 1996 |
[Diagnosis and treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Polymerase Chain Reaction; Ranitidine | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
[Recent topics on Helicobacter pylori--Historic background and problems caused by bacteria].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1998 |
[Efficacy of antibiotic therapy in eradicating Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 1998 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Stomach Ulcer | 1999 |
The gastric demon. An update on Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nurse Practitioners; Peptic Ulcer; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Stomach Neoplasms | 2001 |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethnicity; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Penicillins; Population Surveillance; Prevalence; Risk Factors; Sex Factors; Stomach Ulcer; United States | 2002 |
Ulcer and gastritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Precancerous Conditions; Proton Pump Inhibitors; Rifabutin; Stomach Neoplasms | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
111 trial(s) available for clarithromycin and Gastritis
| Article | Year |
|---|---|
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
Topics: Amoxicillin; Clarithromycin; Drug Costs; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Myanmar; Rabeprazole; Tinidazole; Treatment Outcome | 2020 |
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2020 |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Compounds | 2017 |
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Probiotics; Prospective Studies; Proton Pump Inhibitors; Serbia; Time Factors; Treatment Outcome; Young Adult | 2016 |
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dizziness; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nausea; Patient Compliance; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2018 |
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome | 2019 |
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial.
Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Patient Compliance; Tinidazole; Treatment Failure; Treatment Outcome; Young Adult | 2018 |
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Omeprazole; Treatment Outcome | 2013 |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome | 2014 |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome | 2014 |
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Probiotics; Prognosis; Prospective Studies; Salicylates; Thailand | 2014 |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Ulcer; Time Factors; Treatment Outcome | 2015 |
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2015 |
Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult | 2015 |
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Pantoprazole; Peptic Ulcer; Tinidazole | 2015 |
[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pancreatitis, Chronic; Pantoprazole; Synbiotics | 2014 |
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus delbrueckii; Male; Metronidazole; Middle Aged; Probiotics; Prognosis; Prospective Studies; Streptococcus; Young Adult | 2015 |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Sequence Analysis, DNA; Stomach Neoplasms | 2016 |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Time Factors; Treatment Outcome | 2017 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Gene Frequency; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Logistic Models; Male; Middle Aged; Odds Ratio; Pantoprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure | 2009 |
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Rabeprazole; Young Adult | 2008 |
Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Biopsy; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Expectorants; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Thioglycolates; Thiophenes; Treatment Outcome | 2010 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hypothyroidism; Male; Metronidazole; Middle Aged; Tetracycline; Thyrotropin; Thyroxine; Triiodothyronine | 2011 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hydroxybenzoates; Male; Metronidazole; Nitrofurans; Pantoprazole; Peptic Ulcer; Treatment Outcome | 2011 |
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Stomach Ulcer; Tinidazole | 2012 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2002 |
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome | 2003 |
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Enzyme Induction; Gastric Mucosa; Gastritis; Gene Expression Regulation, Enzymologic; Helicobacter pylori; Humans; Immunoenzyme Techniques; Intestinal Mucosa; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Pyloric Antrum; RNA, Messenger | 2003 |
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Patient Compliance; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2004 |
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Omeprazole; Peptic Ulcer; Retrospective Studies | 2004 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metaplasia; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
[Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Rabeprazole | 2004 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Brazil; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Promoter Regions, Genetic; Prospective Studies | 2006 |
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 2006 |
Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytokines; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter pylori; Humans; Interleukins; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Proton Pump Inhibitors; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2006 |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Furazolidone-based triple therapy for H pylori gastritis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lactobacillus acidophilus; Male; Metronidazole; Middle Aged; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole; Treatment Outcome | 2006 |
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome; Urease | 2007 |
[Age and eradication treatment of duodenal ulcer].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Severity of Illness Index; Treatment Outcome | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Omeprazole; Receptors, Immunologic; Severity of Illness Index; Stomach Ulcer; Tissue Culture Techniques; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha | 2007 |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ecuador; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2008 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 1995 |
Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Clarithromycin; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole | 1995 |
Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1995 |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
Topics: Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1995 |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, Digestive System; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach; Stomach Ulcer; Stomatitis; Sulfoxides | 1995 |
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1995 |
Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1994 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tinidazole; Treatment Failure | 1996 |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antibodies, Bacterial; Azithromycin; Biomarkers; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pepsinogens | 1996 |
One week treatment for Helicobacter pylori infection.
Topics: Adolescent; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Metronidazole; Organometallic Compounds | 1997 |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Peptic Ulcer; Pyloric Antrum; Treatment Outcome | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
[Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
Topics: Abdominal Pain; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Longitudinal Studies; Male; Prospective Studies; Ranitidine; Recurrence | 1996 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1996 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method | 1997 |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins | 1996 |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acid; Gastric Emptying; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pepsinogens; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 1998 |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tinidazole | 1998 |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole | 1998 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Treatment Outcome | 1998 |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Prospective Studies; Time Factors | 1999 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer | 1999 |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Severity of Illness Index; Sulfoxides; Treatment Outcome | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Ethics, Medical; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Risk Factors; Stomach Neoplasms | 1999 |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Smoking | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1999 |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis; Female; Food; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Penicillins; Polyethylene Glycols; Postprandial Period; Solvents | 1999 |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Duodenum; Dyspepsia; Female; Gastritis; Gastrointestinal Motility; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Manometry; Middle Aged; Myoelectric Complex, Migrating; Stomach | 1999 |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Double-Blind Method; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Patient Compliance; Proton Pump Inhibitors; Quality Control; Sulfoxides; Treatment Outcome; Urea | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bronchitis; Clarithromycin; Diarrhea; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Pantoprazole; Patient Compliance; Sulfoxides; Time Factors; Treatment Outcome | 2000 |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Treatment Failure; Vomiting | 2000 |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Omeprazole; Prospective Studies | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Stomach; Sulfoxides; Time Factors | 2000 |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aminopyrine; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Radioisotopes; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides | 2000 |
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole | 2000 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors | 2000 |
Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.
Topics: Animals; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Milk; Pyloric Antrum | 2001 |
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Confidence Intervals; Culture Techniques; Drug Resistance, Microbial; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Prevalence; Probability; Risk Factors; Sex Distribution; Statistics, Nonparametric | 2000 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Tinidazole | 2000 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pain Measurement; Penicillins; Quality of Life; Ranitidine; Treatment Outcome | 2001 |
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies; Treatment Outcome | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Metronidazole; Omeprazole; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2001 |
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Treatment Outcome | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids | 2001 |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms | 2001 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Smoking; Time Factors | 2002 |
184 other study(ies) available for clarithromycin and Gastritis
| Article | Year |
|---|---|
Identification of 3',4',5'-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Chalcones; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Host-Pathogen Interactions; Humans; Interleukin-8; NF-kappa B | 2010 |
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell Line; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoblotting; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2012 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach; Stomach Neoplasms; Tinidazole | 2021 |
Octreotide-based therapies effectively protect mice from acute and chronic gastritis.
Topics: Animals; Clarithromycin; Ethanol; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Inflammation; Male; Mice; Mice, Inbred C57BL; Octreotide; Omeprazole | 2022 |
Assessment of Helicobacter pylori positive infected patients according to Clarithromycin resistant 23S rRNA, rpl22 associated mutations and cyp2c19*1, *2, *3 genes pattern in the Early stage of Gastritis.
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Mutation; Proton Pump Inhibitors; Ribosomal Proteins; RNA, Ribosomal, 23S | 2022 |
Rare finding of duodenal lymphangioma in a patient with Helicobacter pylori associated gastritis: A case report.
Topics: Adult; Child; Clarithromycin; Duodenum; Gastritis; Helicobacter pylori; Humans; Lymphangioma; Male | 2022 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline; Ulcer | 2022 |
RELATIONSHIP OF HELICOBACTER PYLORI CAGA AND VACA STATUS TO MORPHOLOGICAL CHANGES OF GASTRIC MUCOSA AND PRIMARY CLARITHROMYCIN RESISTANCE RATE IN PATIENTS WITH CHRONIC GASTRITIS: A CROSS-SECTIONAL STUDY.
Topics: Atrophy; Bacterial Proteins; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation | 2023 |
Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atherosclerosis; Cholesterol, HDL; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Metabolism; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Mutations in the Helicobacter pylori 23S rRNA gene associated with clarithromycin resistance in patients at an endoscopy unit in Medellín, Colombia
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Colombia; Cross-Sectional Studies; Drug Resistance, Bacterial; Dyspepsia; Female; Gastritis; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation, Missense; Point Mutation; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Young Adult | 2019 |
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2019 |
Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancer.
Topics: Areca; Clarithromycin; Cost of Illness; Drug Therapy, Combination; Gastritis; Healthcare Disparities; Helicobacter Infections; Helicobacter pylori; Incidence; Indigenous Peoples; Prevalence; Risk Factors; Smoking; Stomach Neoplasms; Taiwan | 2020 |
[Helicobacter pylori infection. Frequency of first-line treatment failure].
Topics: Amoxicillin; Anti-Bacterial Agents; Argentina; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2020 |
The Relationship between the Sydney Classification and the First-Line Treatment Efficacy in Helicobacter-Associated Gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Middle Aged; Pantoprazole; Severity of Illness Index | 2020 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Chromatography, High Pressure Liquid; Clarithromycin; Cytokines; DNA, Bacterial; Drug Evaluation, Preclinical; Flowers; Gastric Mucosa; Gastritis; Glycyrrhiza; Helicobacter Infections; Helicobacter pylori; Immunoglobulin G; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Omeprazole; Pinus; Plant Extracts; Specific Pathogen-Free Organisms | 2020 |
High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Vietnam | 2020 |
Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by
Topics: Amoxicillin; Animals; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Proton Pump Inhibitors; Rabeprazole; Sucralfate | 2020 |
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2020 |
Changes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Tomography | 2021 |
Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Narrow Band Imaging; Rabeprazole; Stomach Diseases | 2017 |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Dog Diseases; Dogs; Gastric Mucosa; Gastritis; Gastrointestinal Hormones; Gene Expression; Helicobacter Infections; Peptide Hormones; Real-Time Polymerase Chain Reaction; Stomach | 2017 |
Impact of health insurance coverage for
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Gastritis; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Insurance Coverage; Insurance, Health; Japan; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2017 |
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Pharmacogenomic Variants; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure | 2019 |
Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Clarithromycin; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Precision Medicine; RNA, Ribosomal, 23S; Young Adult | 2019 |
Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Point Mutation; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Vietnam; Young Adult | 2019 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Incidental Findings; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Tinidazole | 2018 |
Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
Topics: Anti-Bacterial Agents; Clarithromycin; Dysbiosis; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Time Factors | 2019 |
Endoscopic and Histological Findings among Israeli Populations Infected with Helicobacter pylori: Does Ethnicity Matter?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Arabs; Biopsy; Clarithromycin; Demography; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Jews; Male; Middle Aged; Risk Factors; Socioeconomic Factors | 2019 |
Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Amoxicillin; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prevalence; Treatment Outcome | 2019 |
Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pakistan; Peptic Ulcer; Prevalence; Recurrence; Treatment Outcome; Young Adult | 2013 |
Case report: Helicobacter suis infection in a pig veterinarian.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Histocytochemistry; Humans; Male; Microscopy; Occupational Exposure; Pantoprazole; Polymerase Chain Reaction; Swine; Treatment Outcome; Veterinarians | 2013 |
Dissociative disorder induced by clarithromycin combined with rabeprazole in a patient with gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clarithromycin; Dissociative Disorders; Drug Therapy, Combination; Female; Gastritis; Humans; Middle Aged; Rabeprazole | 2013 |
PCR detection of clarithromycin-susceptible and -resistant Helicobacter pylori from formalin-fixed, paraffin-embedded gastric biopsies.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Fixatives; Formaldehyde; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Microbial Sensitivity Tests; Paraffin Embedding; Point Mutation; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies; RNA, Ribosomal, 23S; Stomach; Tissue Fixation | 2013 |
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2013 |
Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2013 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
Might Helicobacter pylori infection be associated with distortion on taste perception?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Clarithromycin; Dysgeusia; Female; Gastritis; Gastroscopy; Ghana; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Metronidazole; Olfaction Disorders; Pantoprazole; Polymerase Chain Reaction; Saliva; Taste Perception; Urease; Young Adult | 2013 |
Granulomatous gastritis and Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Esomeprazole; Female; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Symptom Assessment; Treatment Outcome | 2013 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Duodenal Ulcer; Duodenitis; Ethylenediamines; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Stomach Ulcer | 2013 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Young Adult | 2013 |
Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism.
Topics: Amoxicillin; Child; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Severity of Illness Index; Treatment Outcome | 2014 |
Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Neutrophil Infiltration | 2014 |
Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Endoscopy; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Base Sequence; China; Clarithromycin; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minority Groups; Molecular Sequence Data; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; Ribotyping; Treatment Outcome | 2014 |
[Determination of single nucleotide mutations in the 23S rRNA gene of Helicobacter pylori related to clarithromycin resistance in a population from Cauca, Colombia].
Topics: Adolescent; Adult; Aged; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastritis; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mutation, Missense; Polymorphism, Single Nucleotide; Prospective Studies; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Alignment; Sequence Homology, Nucleic Acid; Young Adult | 2014 |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Disease; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HIV Infections; HIV-1; Humans; Male; Middle Aged; Omeprazole | 2014 |
The Helicobacter pylori resistance rate to clarithromycin in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation, Missense; Peptic Ulcer; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 23S; Young Adult | 2015 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Probiotics; Stomach Neoplasms | 2014 |
Ultimate eradication rate of Helicobacter pylori after first, second, or third-line therapy in Korea.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Logistic Models; Male; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 2015 |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Time Factors; Tokyo | 2014 |
[Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
Topics: Abdominal Pain; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Probiotics; Proton Pump Inhibitors; Treatment Outcome | 2014 |
The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode.
Topics: Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Delusions; Female; Gastritis; Hallucinations; Humans; Middle Aged; Psychoses, Substance-Induced | 2015 |
Not All Helicobacter Are pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Biopsy; Clarithromycin; Endoscopy, Digestive System; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Histocytochemistry; Humans; Male; Metronidazole; Microscopy; Pantoprazole; Proton Pump Inhibitors | 2015 |
Comment on The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode.
Topics: Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Female; Gastritis; Humans; Psychoses, Substance-Induced | 2015 |
Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moxifloxacin; Peptic Ulcer; Risk Factors; Young Adult | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Autophagy; Case-Control Studies; Cathelicidins; Clarithromycin; Extracellular Traps; Female; Gastritis; Helicobacter Infections; Humans; Immunologic Factors; Male; Middle Aged; Neutrophils | 2016 |
High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Prognosis; RNA, Ribosomal, 23S; Stomach; Thailand; Young Adult | 2015 |
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples.
Topics: Aged; Aged, 80 and over; Base Sequence; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; RNA, Bacterial; RNA, Ribosomal, 23S; Sequence Analysis, RNA; Stomach; Therapeutic Irrigation | 2016 |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Proton Pump Inhibitors; Retrospective Studies; RNA, Ribosomal, 23S; Treatment Failure; United States; Young Adult | 2016 |
Severe Helicobacter pylori gastritis-related thrombocytopenia and iron deficiency anemia in an adolescent female.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Breath Tests; Clarithromycin; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins, Intravenous; Iron; Lansoprazole; Purpura, Thrombocytopenic; Remission Induction | 2016 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Spain; Stomach Ulcer | 2016 |
[Quadruple therapy is more effective against H. pylori].
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors | 2016 |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2017 |
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Disease; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mutation; RNA, Ribosomal, 23S; Virulence | 2016 |
Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection.
Topics: Amoxicillin; Clarithromycin; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Humans; Male; Middle Aged; Rabeprazole | 2016 |
Eosinophilic gastroenteritis: a challenge to diagnose and treat.
Topics: Acetates; Adult; Anti-Bacterial Agents; Azathioprine; Biopsy; Budesonide; Clarithromycin; Cyclopropanes; Endoscopy; Enteritis; Eosinophilia; Eosinophils; Female; Gastritis; Gastroenteritis; Humans; Leukocyte Count; Macrolides; Mucous Membrane; Quinolines; Sulfides | 2016 |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Early Detection of Cancer; Evidence-Based Medicine; Fluoroquinolones; Gastritis; Gastrointestinal Microbiome; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach; Stomach Neoplasms | 2017 |
[Palpable purpura with severe pruritus].
Topics: Aged; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Prognosis; Pruritus; Purpura; Vasculitis, Leukocytoclastic, Cutaneous | 2008 |
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alopecia; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colonic Polyps; Colonoscopy; Gastritis; Helicobacter Infections; Humans; Hyperpigmentation; Intestinal Polyposis; Lansoprazole; Male; Syndrome | 2008 |
[Eosinophilic gastritis after helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endosonography; Eosinophilia; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Pantoprazole | 2008 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitric Oxide; Omeprazole; Proton Pump Inhibitors | 2009 |
Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Ireland; Male; Metronidazole; Middle Aged; Prevalence | 2010 |
[Acute psychosis induced by a Helicobacter pylori (H. pylori)-eradication treatment with amoxicillin, clarithromycin and pantoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Delusions; Drug Interactions; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Pantoprazole; Psychoses, Substance-Induced | 2010 |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Prospective Studies; Tunisia; Young Adult | 2010 |
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clarithromycin; Cyclophosphamide; Gastritis; Helicobacter Infections; Helicobacter pylori; Herpesvirus 8, Human; HIV Seronegativity; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Prednisone; Proton Pump Inhibitors; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Vinblastine; Vincristine | 2010 |
Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Image Enhancement; Lansoprazole; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index | 2011 |
Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.
Topics: Adolescent; Austria; Biopsy; Child; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Dyspepsia; Feces; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Retrospective Studies | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
Role of gastritis pattern on Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2012 |
Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Singapore; Treatment Outcome; Young Adult | 2013 |
Successful treatment of eosinophilic gastroenteritis with clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Enteritis; Eosinophilia; Gastritis; Humans; Immunologic Factors; Male; Middle Aged; Prednisolone | 2012 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.
Topics: Amoxicillin; Animals; Anti-Infective Agents, Local; Clarithromycin; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Metronidazole; Mucus; Rats; Rats, Wistar | 2002 |
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Quinolones | 2002 |
Helicobacter pylori hiccup.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esophagitis; Gastritis; Helicobacter Infections; Helicobacter pylori; Hiccup; Humans; Male; Omeprazole; Treatment Outcome | 2003 |
Helicobacter pylori and antimicrobial susceptibility in children.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2003 |
Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2003 |
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole | 2003 |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2003 |
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retrospective Studies | 2003 |
[Influence of long-term macrolide therapy for chronic inflammation of respiratory tract on concurrent helicobacter pylori infection of stomach].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Respiratory Tract Diseases; Retrospective Studies; Time Factors | 2003 |
[Effect of clarithromycin on pathogenic factors in Helicobacter pylori].
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Antibody Formation; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagella; Gastric Mucosa; Gastritis; Heat-Shock Proteins; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Movement; Urease | 2003 |
Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue.
Topics: Anti-Bacterial Agents; Carbocyanines; Clarithromycin; Drug Resistance, Bacterial; Fluorescein; Formaldehyde; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Macrolides; Reproducibility of Results; Stomach; Tissue Fixation | 2004 |
Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Culture Media; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Reference Standards | 2004 |
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Platelet Count; Remission Induction; Thrombocytopenia | 2004 |
Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.
Topics: Adult; Amoxicillin; Breath Tests; Child; Clarithromycin; Disease Transmission, Infectious; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Urea | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer; Treatment Outcome | 2004 |
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens; Biopsy; Breath Tests; Clarithromycin; Colony Count, Microbial; Cytological Techniques; Dyspepsia; Endoscopy, Gastrointestinal; Feces; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2004 |
Acute colchicine intoxication during clarithromycin administration.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Gastritis; Gout Suppressants; Helicobacter pylori; Humans; Male; Omeprazole | 2004 |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Female; Gastritis; Half-Life; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Immunoglobulin G; Lansoprazole; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Omeprazole; Penicillins; Sucralfate; Viscosity | 2004 |
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Male; Omeprazole; Specific Pathogen-Free Organisms | 2005 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies; Autoimmune Diseases; Bacterial Proteins; Breath Tests; Celiac Disease; Child; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Ferrous Compounds; Gastrins; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prospective Studies; Urease; Vitamin B 12 Deficiency | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Biopsy; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome | 2005 |
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Microscopy, Electron, Transmission; Middle Aged; Omeprazole; Stomach; Treatment Outcome | 2005 |
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin; Complement C3c; Complement Inactivator Proteins; Complement System Proteins; Female; Gastric Mucosa; Gastritis; Glycosylphosphatidylinositols; Helicobacter Infections; Helicobacter pylori; Humans; Male; Membrane Cofactor Protein; Middle Aged; Omeprazole; Peptic Ulcer; Receptors, Complement | 2005 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins | 2006 |
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphocytes; Male; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
[Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Prevalence | 2004 |
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Stomach Ulcer | 2005 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline | 2006 |
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Ranitidine; Treatment Outcome | 2005 |
Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina.
Topics: Argentina; Bacterial Outer Membrane Proteins; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Point Mutation; RNA, Ribosomal, 23S; Stomach Neoplasms | 2006 |
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure.
Topics: Amoxicillin; Anti-Bacterial Agents; Biomarkers; Biopsy; Body Weight; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Follow-Up Studies; Gastric Mucosa; Gastritis; Gene Expression; Ghrelin; Growth Hormone; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Middle Aged; Peptide Hormones; Prognosis; Proton Pump Inhibitors; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Fluoroquinolones; Gastritis; Helicobacter pylori; Humans; Metronidazole; Pyloric Antrum | 2006 |
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Stomach Ulcer | 2007 |
Influence of H pylori on plasma ghrelin in patients without atrophic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Peptide Hormones; Turkey | 2007 |
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers, Tumor; Case-Control Studies; CDX2 Transcription Factor; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Homeodomain Proteins; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Metaplasia; Middle Aged; Pepsinogen A; Precancerous Conditions; Stomach Neoplasms | 2007 |
Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; DNA Primers; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Peptic Ulcer; Phenotype; Polymerase Chain Reaction; RNA, Ribosomal, 23S | 2007 |
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors | 2008 |
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Middle Aged; Phenotype; Prospective Studies; Stomach; Stomach Neoplasms; Tropomyosin; Tumor Suppressor Protein p53 | 2008 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tetracycline | 1995 |
Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels.
Topics: Adult; Carbamazepine; Clarithromycin; Drug Interactions; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tetracycline | 1995 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer | 1995 |
Therapy with omeprazole and clarithromycin increases serum carbamazepine levels in patients with H. pylori gastritis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Carbamazepine; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1996 |
Italian omeprazole triple therapy--a 1-week regimen.
Topics: Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Omeprazole; Time Factors; Tinidazole | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Atopic dermatitis successfully treated by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Western; Clarithromycin; Dermatitis, Atopic; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 1996 |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Roxithromycin; Treatment Outcome | 1996 |
[Time course of disappearance of Helicobacter pylori after topical therapy and new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Time Factors | 1997 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Metronidazole; Omeprazole; Pyloric Antrum; Time Factors | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Gastritis; Germany; Helicobacter Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum | 1997 |
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Fever; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male | 1997 |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Prospective Studies; Time Factors; Wound Healing | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Superoxide Dismutase | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Male; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1998 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
Leukocytoclastic vasculitis associated with clarithromycin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Duodenitis; Female; Gastritis; Humans; Vasculitis, Leukocytoclastic, Cutaneous | 1998 |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Clarithromycin; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Stomach; Tetracycline; Urease | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1998 |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection.
Topics: Adolescent; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole | 1998 |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Granulocytes; Helicobacter; Helicobacter Infections; Humans; Male; Omeprazole; Penicillins | 1999 |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Retreatment; Treatment Failure | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis.
Topics: Anti-Bacterial Agents; Biopsy; Cell Division; Clarithromycin; DNA Damage; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Metronidazole | 1999 |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Risk Factors; Treatment Outcome | 2000 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
Iron-deficiency anemia associated with Helicobacter pylori gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Endoscopy, Gastrointestinal; Feces; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Lansoprazole; Male; Metronidazole; Omeprazole; Stomach; Urea | 2000 |
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan.
Topics: Anti-Bacterial Agents; Biopsy; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Gastritis; Helicobacter pylori; Humans; Japan; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Stomach Neoplasms | 2000 |
Helicobacter pylori infection in recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Recurrence; Retrospective Studies; Stomach; Switzerland | 2000 |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastritis; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer | 2000 |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Male; Omeprazole; Penicillins | 2000 |
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine | 2001 |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Therapy, Combination; Female; Gastric Emptying; Gastritis; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Neurologic Examination; Omeprazole | 2001 |
[Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care].
Topics: Amoxicillin; Biopsy; Clarithromycin; Drug Resistance, Microbial; Duodenoscopy; Enzyme-Linked Immunosorbent Assay; Europe; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Primary Health Care; Proton Pump Inhibitors; Serologic Tests; Societies, Medical | 2000 |
Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cell Division; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Movement; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Sulfides; Treatment Failure | 2001 |
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Common Bile Duct Neoplasms; Drug Therapy, Combination; Duodenal Neoplasms; Endosonography; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Lymphoma, Follicular; Male; Middle Aged; Omeprazole | 2001 |
Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Severity of Illness Index | 2001 |
Clinical and endoscopic improvement of lymphocytic gastritis with eradication of Helicobacter pylori.
Topics: Aged; Anemia, Iron-Deficiency; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypoproteinemia; Lymphocytes; Male | 2001 |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.
Topics: Adult; Antiphospholipid Syndrome; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Immunoglobulin M; Metronidazole; Omeprazole; Time Factors | 2001 |
Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Wound Healing | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Gastritis; Humans; Metronidazole; Omeprazole; Stomach Ulcer | 2000 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Population Surveillance; Prevalence; Risk Factors; Stomach Ulcer; United States | 2002 |
[Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Topics: Adolescent; Adult; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Occupational Diseases; Omeprazole; Prospective Studies; Treatment Outcome | 2002 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2002 |
Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children.
Topics: Abdominal Pain; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Humans; Male; Penicillins; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2002 |
Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antigen-Presenting Cells; CD28 Antigens; Cell Count; Clarithromycin; Drug Therapy, Combination; Fluorescent Antibody Technique, Indirect; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Macrophages; Metronidazole; Omeprazole; Treatment Outcome | 2002 |
Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Family; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence | 2002 |
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarithromycin; Coloring Agents; Dental Plaque; Drug Therapy, Combination; Female; Fluorescent Dyes; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Tongue | 2001 |